Preferred Label : Mouse Myeloid Proliferation;
Alternative definition : MMHCC: Disorder is not a myeloid dysplasia [if a disorder satisfied criterion 1 for
myeloid proliferation (non-reactive) but also fulfills criteria for myeloid dysplasia
the diagnosis of myeloid dysplasia should be applied].; MMHCC: Disorder is not a non-lymphoid leukemia; if a disorder satisfied criterion
1 for myeloid proliferation (non-reactive) but also fulfills criteria for non-lymphoid
leukemia the diagnosis of non-lymphoid leukemia should be applied.; MMHCC: Comment: Intended to encompass diseases more closely related to human myelodysplastic/myeloproliferative
or myeloproliferative diseases than to human myelodysplastic syndromes. Myeloid proliferations
(nonreactive) may be morphologically indistinguishable from reactive processes. Reactive
cause for increased numbers of nonlymphoid hematopoietic cells should be considered.
By definition, this diagnosis is for lesions that are nonreactive, persistent, and
genetically determined.; MMHCC: Mice exhibit increased non-lymphoid hematopoietic cells as evidenced by any
combination of; A: Erythrocytosis, leukocytosis of myeloid cells, and/or thrombocytosis/circulating
megakaryocytes B: Increased non-lymphoid hematopoietic cells in spleen and/or bone
marrow.;
PubMed : 8681380; 7926784; 8563750; 9052833; 2653457; 2565534; 1437146; 10602472; 2824063; 10393173;
Origin ID : C21901;
UMLS CUI : C1513644;
Semantic type(s)
- eo_disease_has_associated_eo_anatomy
- eo_disease_maps_to_human_disease
